partner search
... Main research areas: molecular biology,genomics,identification of disease patterns Short description: In recent years, worldwide and in Kazakhstan, the number of patients with asthma and chronic obstructive pulmonary disease (COPD) progressively increases. Genetic susceptibility and environmental fa ...
... Main research areas: molecular biology,genomics,identification of disease patterns Short description: In recent years, worldwide and in Kazakhstan, the number of patients with asthma and chronic obstructive pulmonary disease (COPD) progressively increases. Genetic susceptibility and environmental fa ...
Respiratory Disorders
... Symptoms usually last about 1 week Treatment: take medications to treat symptoms (analgesic, antipyretics, rest, antihistamines) ...
... Symptoms usually last about 1 week Treatment: take medications to treat symptoms (analgesic, antipyretics, rest, antihistamines) ...
Smoke and your health - Tasmania Fire Service
... smoke. However changes in weather conditions and other factors can affect where smoke from a planned burn may travel. If people can smell smoke, it can be a risk to their health and they need to ensure they take the necessary precautions to protect themselves against it. ...
... smoke. However changes in weather conditions and other factors can affect where smoke from a planned burn may travel. If people can smell smoke, it can be a risk to their health and they need to ensure they take the necessary precautions to protect themselves against it. ...
Allergic reactions
... The immune system begins making a special type of antibody to these substances, which under normal conditions would not stimulate the immune system. These antibodies cause cells in the body to release histamines, which cause many allergic symptoms, such as extra fluid in the nasal pathways, difficul ...
... The immune system begins making a special type of antibody to these substances, which under normal conditions would not stimulate the immune system. These antibodies cause cells in the body to release histamines, which cause many allergic symptoms, such as extra fluid in the nasal pathways, difficul ...
Pulmonary Oedema
... associated plasma exudation, oedema, smooth muscle hypertrophy, mucous plugging and epithelial damage. The disease often ‘flares up’ with viral infections – which often cause a loud wheeze. Aetiology Intrinsic – this often starts in middle age, and is sometimes called late onset asthma. You cannot f ...
... associated plasma exudation, oedema, smooth muscle hypertrophy, mucous plugging and epithelial damage. The disease often ‘flares up’ with viral infections – which often cause a loud wheeze. Aetiology Intrinsic – this often starts in middle age, and is sometimes called late onset asthma. You cannot f ...
Construction of a new strain of mice that lack mast cells and set
... Construction of a new strain of mice that lack mast cells and set-up of a mouse asthma model Behdad Zarnegar Asthma is a chronic inflammatory disease of the airways which causes recurrent episodes of coughing, wheezing, chest tightness and ...
... Construction of a new strain of mice that lack mast cells and set-up of a mouse asthma model Behdad Zarnegar Asthma is a chronic inflammatory disease of the airways which causes recurrent episodes of coughing, wheezing, chest tightness and ...
Generation of CNS-1 deficient mice
... Asthma reaches prevalence levels of 8%-12% in some urban Westernized populations. Allergic asthma is predominantly a disease of childhood. Consider the impact of genetics, environment and development in constructing a model to explain the immunologic underpinnings explaining the increasing prevalenc ...
... Asthma reaches prevalence levels of 8%-12% in some urban Westernized populations. Allergic asthma is predominantly a disease of childhood. Consider the impact of genetics, environment and development in constructing a model to explain the immunologic underpinnings explaining the increasing prevalenc ...
PowerPoint - UCSF Immunology Program
... Asthma reaches prevalence levels of 8%-12% in some urban Westernized populations. Allergic asthma is predominantly a disease of childhood. Consider the impact of genetics, environment and development in constructing a model to explain the immunologic underpinnings explaining the increasing prevalenc ...
... Asthma reaches prevalence levels of 8%-12% in some urban Westernized populations. Allergic asthma is predominantly a disease of childhood. Consider the impact of genetics, environment and development in constructing a model to explain the immunologic underpinnings explaining the increasing prevalenc ...
Application of management guidelines to the assessment of new
... drive improved management of COPD. However, the guidelines have also been used increasingly by regulatory authorities to define the requirements for new agents to gain approval, a role that they were never designed to fill. The GOLD guidelines provide a working definition of COPD as a disease state ...
... drive improved management of COPD. However, the guidelines have also been used increasingly by regulatory authorities to define the requirements for new agents to gain approval, a role that they were never designed to fill. The GOLD guidelines provide a working definition of COPD as a disease state ...
Immediate Hypersensitivity (Hypersensitivity type 1)
... 1 – seasonal allergic rhinitis ( SAR ) : - often related with outdoor allergens - tree pollens in early spring - grass pollens in spring & summer - weed pollens in summer & autumn ...
... 1 – seasonal allergic rhinitis ( SAR ) : - often related with outdoor allergens - tree pollens in early spring - grass pollens in spring & summer - weed pollens in summer & autumn ...
causes
... with particular sign or symptom • The techniques of examination • Be able to correlate the findings with common diseases ...
... with particular sign or symptom • The techniques of examination • Be able to correlate the findings with common diseases ...
Document
... MARKED THICKENING OF THE BASEMENT MEMBRANE OF BRONCHIAL MUCOSA, HYPERTROPHY OF BRONCHIAL SMOOTH MUSCLE, HYPERTROPHY OF BRONCHIAL MUCOUS GLANDS, EOSINOPHILS AND CHRONIC INFLAMMATORY CELLS IN THE BRONCHIAL WALL, INC. NUMBER OF MAST CELLS, PRESENCE OF MUCOUS IN BRONCHI CONTAINING LARGE NUMBERS OF EOSIN ...
... MARKED THICKENING OF THE BASEMENT MEMBRANE OF BRONCHIAL MUCOSA, HYPERTROPHY OF BRONCHIAL SMOOTH MUSCLE, HYPERTROPHY OF BRONCHIAL MUCOUS GLANDS, EOSINOPHILS AND CHRONIC INFLAMMATORY CELLS IN THE BRONCHIAL WALL, INC. NUMBER OF MAST CELLS, PRESENCE OF MUCOUS IN BRONCHI CONTAINING LARGE NUMBERS OF EOSIN ...
INTERNATIONAL MEDICAL REVIEW ON DOWN`S SYNDROME
... responsible for the production of antibodies against parasites and allergens, with other cytokines involved (IL-4, IL-13, etc.). The Th1/Th2 response is balanced, such that the production of antibodies against pathogens is guaranteed by the superior activity of Th1. The production of allergenspecifi ...
... responsible for the production of antibodies against parasites and allergens, with other cytokines involved (IL-4, IL-13, etc.). The Th1/Th2 response is balanced, such that the production of antibodies against pathogens is guaranteed by the superior activity of Th1. The production of allergenspecifi ...
Asthma and immune dysregulation: A tale of antibodies “gone bad”
... Reactive airway disease (RAD or “asthma”) results from reversible airway obstruction, which can be triggered by a variety of mechanisms. Although bronchial constriction can be induced by exposure to cold air, by viral or Mycoplasma infections, or by local irritants such as sulfur dioxide, more than ...
... Reactive airway disease (RAD or “asthma”) results from reversible airway obstruction, which can be triggered by a variety of mechanisms. Although bronchial constriction can be induced by exposure to cold air, by viral or Mycoplasma infections, or by local irritants such as sulfur dioxide, more than ...
Asthma Therapy for 2006
... • Topical nasal steroids are the most potent treatment for allergic rhinitis • Anticholinergic nasal sprays may help for vasomotor rhinitis/non allergic rhinitis • Mast cell stabilizers must be used several times a day for many days before it starts working • Nasal decongestant cause a rebound effe ...
... • Topical nasal steroids are the most potent treatment for allergic rhinitis • Anticholinergic nasal sprays may help for vasomotor rhinitis/non allergic rhinitis • Mast cell stabilizers must be used several times a day for many days before it starts working • Nasal decongestant cause a rebound effe ...
MU Brno - med.muni
... Basophils are granulocytes that circulate in the blood of most vertebrates, in humans, they account for 0,5-1,0% of the circulating white blood cells. ...
... Basophils are granulocytes that circulate in the blood of most vertebrates, in humans, they account for 0,5-1,0% of the circulating white blood cells. ...
Asbestos Related Lung Disease
... “Disease characterized by variable airflow obstruction and/or airway hyper-responsiveness due to causes and conditions attributable to a particular work environment and not to stimuli encountered outside the workplace” • It is usually new-onset asthma, but can occur in people with pre-existing asthm ...
... “Disease characterized by variable airflow obstruction and/or airway hyper-responsiveness due to causes and conditions attributable to a particular work environment and not to stimuli encountered outside the workplace” • It is usually new-onset asthma, but can occur in people with pre-existing asthm ...
021709.M1-Immuno.AllergySelfStudy
... the severity of atopic diseases. The IL-4 receptor-a gene is one example. Other genes may have an influence on the response to medications used in treating allergic diseases ...
... the severity of atopic diseases. The IL-4 receptor-a gene is one example. Other genes may have an influence on the response to medications used in treating allergic diseases ...
Full Text Article - European Journal of Biomedical and
... Asthma is a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role. causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. These episodes cause airflow obstruction, often reversible either spontaneously or with treatment.[1] ...
... Asthma is a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role. causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. These episodes cause airflow obstruction, often reversible either spontaneously or with treatment.[1] ...
Slide 1
... • Late-phase response – Occurs within 4 to 10 hours after initial attack – Can be more severe than early phase and can last for 24 hours or longer – If airway inflammation is not treated or does not resolve, it may lead to irreversible lung damage. ...
... • Late-phase response – Occurs within 4 to 10 hours after initial attack – Can be more severe than early phase and can last for 24 hours or longer – If airway inflammation is not treated or does not resolve, it may lead to irreversible lung damage. ...
The circadian clock and asthma
... overnight, particularly in the early hours of the morning. Nocturnal symptoms in asthma are common and are an important indicator for escalation of treatment. An extensive body of research has demonstrated that nocturnal symptoms of cough and dyspnea are accompanied by circadian variations in airway ...
... overnight, particularly in the early hours of the morning. Nocturnal symptoms in asthma are common and are an important indicator for escalation of treatment. An extensive body of research has demonstrated that nocturnal symptoms of cough and dyspnea are accompanied by circadian variations in airway ...
Asthma
Asthma (from the Greek ἅσθμα, ásthma, ""panting"") is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath.Asthma is thought to be caused by a combination of genetic and environmental factors. Its diagnosis is usually based on the pattern of symptoms, response to therapy over time and spirometry. It is clinically classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic) where atopy refers to a predisposition toward developing type 1 hypersensitivity reactions.Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol) and oral corticosteroids. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or antileukotriene agents may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. The occurrence of asthma has increased significantly since the 1970s. In 2011, 235–300 million people globally were diagnosed with asthma, and it caused 250,000 deaths.
